The (Re-) Emergence of the Age of Enablement: Amgen v. Sanofi
The (Re-) Emergence of the Age of Enablement: Amgen v. Sanofi On May 18, 2023, biotech innovation suffered at least a temporary setback in Amgen v Sanofi in which a unanimous Supreme Court affirmed the rulings of the district court and the Court of Appeals for the Federal Circuit holding that Amgen’s challenged patent …
The (Re-) Emergence of the Age of Enablement: Amgen v. Sanofi Read More »
